ONLINE FIRST
Alyssa Pozniak, PhD; Lois Olinger, MA; Victoria Shier, MA
As the number of patients with diabetes increases, there is growing concern about the adequacy of reimbursement...
FULL TEXT
COMMENTARIES
Scott Gottlieb, MD
Everyone knows that private payers limit access to some health care, but government does it in far more byzantine and arbitrary ways...
FULL TEXT
Betsy McCaughey
Medical professionals are being ignored or vilified more often than consulted in the current healthcare reform debate...
FULL TEXT
EDITORIAL
Robert E. Henry
On October 29, 2009, the 2nd Annual Summit on Stakeholder Integration of AHDB was in progress in Washington, DC, to discuss the need to shift the focus to wellness-based care for chronic diseases...
FULL TEXT
BUSINESS
Maureen Kubacki, PharmD, MBA; Chureen Carter, PharmD, MS; Alan D.L. Herrera, PharmD;
Jim Wang, PhD; Janice M. Lopez, PharmD; Catherine T. Piech, MBA
Insurance claims for patients with CKD average $5000 to $12,000 per patient per year...
FULL TEXT
Stakeholder Perspective by Jeff Januska,
PharmD
REGULATORY
Sara Fernandez-Lopez, PhD; Barbara Lennert, RN, BSN, MAOM
Quality metrics have the potential to increase the value of the US healthcare system by reducing costs and increasing access to...
FULL TEXT
Stakeholder Perspective by Jeffrey A. Bourret,
MS, RPh, FASHP
GENERIC DRUG TRENDS
Dalia Buffery, MA, ABD
The future of generics appears brighter than ever, with many brand-name medications pending patent expiration by 2011, accounting for about $34 billion in total sales in...
FULL TEXT
INDUSTRY TRENDS
Douglas Moeller, MD
Now that gene tests, markers for tumor receptors, and a variety of other molecular probes have created an entirely new world of personalized medicine...
FULL TEXT
